Lantern Pharma Inc. (Nasdaq: LTRN)
Dallas, United States (US) · Health and Medical
Do your work at Lantern Pharma Inc. (Nasdaq: LTRN)?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
#biotechnology
#cancer drug development
#precision medicine
#biomarkers
#genetic screen
#companion diagnostics
#precisiononcology
#artificial intelligence
#patient stratification
#drug rescue
#drug repurposing
Overview
We are dedicated to rescuing and revitalizing abandoned cancer drugs, leveraging cutting-edge machine learning techniques, genomic data, and precision oncology trials to identify new treatment opportunities. Our core mission is to accelerate the development of personalized cancer therapy through AI and genomic-based patient stratification.
Lantern Pharma utilizes its proprietary RADR platform to provide rapid, meaningful insights into patient populations and drug mechanisms, ultimately driving the creation of more effective and targeted cancer treatments. We are committed to transforming the landscape of oncology drug development and improving patient outcomes.
Founded in 2013, Lantern Pharma currently employs 28 people and is publicly traded on Nasdaq under the ticker LTRN.
Contact Details
Dallas, United States (US), 1920 McKinney Ave
+1
Founded
2013
Company Type
Public Limited Company
Employees
20-30
Categories
Keywords
#biotechnology
#cancer drug development
#precision medicine
#biomarkers
#genetic screen
#companion diagnostics
#precisiononcology
#artificial intelligence
#patient stratification
#drug rescue
#drug repurposing
Companies teams usually look at after Lantern Pharma Inc. (Nasdaq: LTRN)
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.